Small Molecules
6 January 2015
Mirati Therapeutics Doses First Patient in Investigator-Sponsored Phase 2 Study of Mocetinostat in Non-Hodgkin’s Lymphoma6 January 2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)6 January 2015
LEO Pharma Announces New Drug Application Submission of the First Aerosol Foam for Plaque Psoriasis6 January 2015
Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive Disorder5 January 2015
Aldeyra Therapeutics Submits IND Filing to FDA for Clinical Testing of NS2 in Patients With Sjogren-Larsson Syndrome5 January 2015
Positive Pre-Clinical Results for Non-Alcoholic Steatohepatitis (NASH) with Anti-fibrotic DS102 Bioactive Lipid31 December 2014
Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial of AQX-1125 in Atopic Dermatitis30 December 2014
Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dyloject™(diclofenac sodium) Injection30 December 2014
Repros Initiates Two Phase 2B Uterine Fibroid Studies29 December 2014
Janssen Announces Collaboration with Gilead to Develop PREZISTA®-based Single-tablet Regimen for the Treatment of People Living with HIV29 December 2014
Safinamide New Drug Application (NDA) Re-submitted to the US Food and Drug Administration (FDA)27 December 2014
Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension27 December 2014
Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled(TM) (Propylene Glycol-Free) Melphalan24 December 2014
Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study24 December 2014
Actavis and Adamas Announce FDA Approval of NamzaricTM, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride23 December 2014
Janssen Receives Positive CHMP Opinion Recommending VELCADE® (bortezomib) for use in Mantle Cell Lymphoma23 December 2014
Roivant Acquires SB742457 From GlaxoSmithKlineNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports